Real-time enrollment status for this alpha 1-antitrypsin clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 3:21 PM UTC
| NCT Number | NCT07135427 |
| Recruiting Status | Recruiting |
| Condition | Alpha 1-Antitrypsin |
| Phase | PHASE4 |
| Target Enrollment | 30 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Alabama at Birmingham |
| Last Updated on CT.gov | November 10, 2025 (Nov 10, 2025) |
As of July 18, 2026: Clinical trial NCT07135427 is currently recruiting participants. This phase4 study for alpha 1-antitrypsin is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Alabama at Birmingham. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07135427 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07135427 was last updated Nov 10, 2025 (November 10, 2025). HelloStudys verifies this status automatically.